BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu M, Liu X, Liu S, Xiao F, Guo E, Qin X, Wu L, Liang Q, Liang Z, Li K, Zhang D, Yang Y, Luo X, Lei L, Tan JHJ, Yin F, Zeng X. Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer. Front Oncol 2020;10:847. [PMID: 32547951 DOI: 10.3389/fonc.2020.00847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Zheng J, Liu J, Zhu T, Liu C, Gao Y, Dai W, Zhuo W, Mao X, He B, Liu Z. Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma. Front Pharmacol 2022;13:895608. [DOI: 10.3389/fphar.2022.895608] [Reference Citation Analysis]
2 Ferreira WAS, de Oliveira EHC. Expression of GOT2 Is Epigenetically Regulated by DNA Methylation and Correlates with Immune Infiltrates in Clear-Cell Renal Cell Carcinoma. CIMB 2022;44:2472-89. [DOI: 10.3390/cimb44060169] [Reference Citation Analysis]
3 Lu W, Hong W, Qiu H, Zhou Z, He Z, Zeng W, Zhong W, Xie J. A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients. Cancer Med 2022. [PMID: 35460212 DOI: 10.1002/cam4.4762] [Reference Citation Analysis]
4 Liu R, Li R, Yu H, Liu J, Zheng S, Li Y, Ye L. NTF3 Correlates With Prognosis and Immune Infiltration in Hepatocellular Carcinoma. Front Med (Lausanne) 2021;8:795849. [PMID: 34938753 DOI: 10.3389/fmed.2021.795849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Feng X, Mu S, Ma Y, Wang W. Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:715728. [PMID: 34660693 DOI: 10.3389/fmolb.2021.715728] [Cited by in F6Publishing: 2] [Reference Citation Analysis]